The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index; 14 of the 44 sources its claims cite were checked for support.
Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service
Open accessAbstract
Background: Chronic postsurgical pain (CPSP) and associated long-term opioid use are major public health concerns. Aims: The Toronto General Hospital Transitional Pain Service (TPS) is a multidisciplinary, hospital-integrated program developed to prevent and manage CPSP and support opioid tapering. This clinical practice–based study reports on preliminary outcomes of the TPS psychology program, which provides acceptance and commitment therapy (ACT) to patients at risk for CPSP and persistent opioid use. Methods: Ninety-one patients received ACT, whereas 252 patients did not (no ACT group). Patient outcomes were compared for the two groups at first and last TPS visits. Pain, pain interference, sensitivity to pain traumatization, pain catastrophizing, anxiety, depression, and opioid use were analyzed using two-way (Group [ACT, no ACT] × Time [first, last visit]) analyses of variance (ANOVAs). Results: Patients referred to ACT were more likely to report a mental health condition preoperatively (P < 0.001), had higher opioid use (P < 0.001) at the first postsurgical visit, and reported higher sensitivity to pain traumatization (P < 0.05) and anxiety (P < 0.05) than the no ACT group at both time points. Both groups showed reductions in pain, pain interference, pain catastrophizing, anxiety, and opioid use by the last TPS visit (P < 0.05). The ACT group demonstrated greater reductions in opioid use and pain interference and showed reductions in depressed mood (P = 0.001) by the end of treatment compared to the no ACT group. Conclusion: Preliminary outcomes suggest that ACT was effective in reducing opioid use while pain interference and mood improved. © 2017 Muhammad Abid Azam, Aliza Z. Weinrib, Janice Montbriand, Lindsay C. Burns, Kayla McMillan, Hance Clarke, and Joel Katz. Published with license by Taylor & Francis.
Overview
CoChat Summary
## TL;DR
This preliminary, nonrandomized clinical practice study found that postsurgical patients in the Toronto General Hospital Transitional Pain Service who received ACT improved over time, with greater reductions in opioid use, pain interference, and depressed mood than patients who did not receive ACT. Both groups improved in several outcomes, but the ACT group started out with higher-risk characteristics and more baseline opioid use.
## Key findings
- Sample and groups: Of 382 TPS patients, 91 received ACT and 252 received no psychology services; 21 assessed by psychology services but not participating in ACT were excluded from analyses.
- Baseline differences: The ACT group was younger (significant group effect for age), more likely to report a preoperative mental health condition (50% vs 28.5%), had higher opioid use at the first postsurgical visit, and had higher sensitivity to pain traumatization and anxiety than the no ACT group.
- Within-group improvement over time: Both groups showed significant reductions by the last TPS visit in pain intensity, pain interference, pain catastrophizing, anxiety, and opioid use.
- ACT-specific advantages: The ACT group had greater reductions in opioid use and pain interference, and only the ACT group showed significant reductions in depressive symptoms; among preoperatively opioid-naïve patients, 65.4% in ACT were completely weaned off opioids versus 41.8% in no ACT.
## Methods
- Design: Clinical practice–based, observational comparison of postsurgical TPS patients who received ACT versus those who did not; outcomes were compared at the first and last post-hospital discharge TPS visits.
- Sample/data: 382 patients attended TPS between April 2014 and November 2016; analyses focused on 91 ACT and 252 no ACT patients, excluding 21 psychology-assessed patients who did not elect ACT.
- Analysis: Two-way ANOVAs tested Group × Time effects for pain, pain interference, sensitivity to pain traumatization, pain catastrophizing, anxiety, depression, and opioid use; age used one-way ANOVA, other baseline characteristics used Kruskal-Wallis or chi-square tests, and some variables were transformed for normality.
## Limitations
- The paper states the study was observational without random assignment, so results may be confounded by treatment indication.
- The paper states the sample size was relatively small, which limited multivariate adjustment and reduced power to detect treatment effects.
- The paper states the surgical cases were heterogeneous, limiting precision and preventing subgroup analyses.
- Evident from the text: the ACT group had more weeks of TPS involvement and more medical visits, so follow-up duration differed between groups and is a confounding variable when comparing outcomes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
7 Valid · 6 Not valid · 15 Not checked · 66 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“A significant proportion of chronic pain and problematic opioid use issues can be linked to the acute phase after major surgery, when patients are commonly prescribed opioid analgesics to manage their postsurgical pain.6,7”
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Introduction Public health concerns related to high-dose, long-term opioid use for the treatment of persistent pain have reached a fever pitch. These concerns are fueled by the lack of evidence for the effectiveness of opioids in adequately treating or alleviating many chronic pain conditions,1 risks of harmful side effects,2 drug diversion and illicit opioid use,3 addictions,4 and fatal overdoses.5 A significant proportion of chronic pain and problematic opioid use issues can be linked to the acute phase after major surgery, when patients are commonly prescribed opioid analgesics to manage their postsurgical pain.6,7 Most patients are provided little more than pharmacotherapy for pain after surgery and are generally offered no intervention targeting the psychological vulnerability factors that are associated with a greater probability of pain chronicity, including pain catastrophizing,8 sensitivity to pain traumatization,9 anxiety and depressive symptoms.10 In addition, although behavioral interventions have been shown to reduce the impact of persistent pain in terms of reducing pain interference (i.e., the impact of pain on work, sleep, relationships, enjoyment of life, etc.),11 postsurgical patients have not historically been offered these interventions. Furthermore, they are typically offered very little medical or behavioral guidance to support opioid weaning,12 given the general expectation that postsurgical pain will resolve and pain medication use will naturally taper in parallel. However, between 5% and 70% of surgery patients develop chronic postsurgical pain (CPSP), depending in part upon the surgical procedure.13 Moreover, 3% and 0.4% of previously opioid-naïve patients continue to use opioids 3 months7 and 1 year after major surgery, respectively, likely due to persistent postsurgical pain.6 Recent U.S. national guidelines for managing postsurgical pain have emphasized that opioids should not constitute a stand-alone treatment for postoperative pain and should be combined with nonpharmacological approaches to prevent long-term opioid use.12 Patients taking a selective serotonin reuptake inhibitor (SSRI) or a benzodiazepine prior to surgery to treat depression or anxiety have been identified as having the highest risk of persisting on opioids following major surgery.6,14 The combination of postsurgical pain, disability, and continued psychological symptoms can be overwhelming for patients in the early recovery period. Thus, a concerted effort must be made to address depression and anxiety in the months after surgery because they have the potential to amplify pain, pain interference, and opioid use.
What the sources say
- Could not verifycites [6] Clarke H, 2014, BMJ sourceExperimental — accuracy not yet measured
The paper’s 'Fiona Godlee editor, BMJ' section discusses minimum alcohol pricing and problem drinking, not surgery or pain treatment. Searches for chronic postsurgical pain, problematic opioid use, and prescribed opioid analgesics found no passage addressing the claim. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [7] Soneji N, 2016, JAMA Surg source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Moreover, 3% and 0.4% of previously opioid-naïve patients continue to use opioids 3 months7 and 1 year after major surgery, respectively, likely due to persistent postsurgical pain.6”
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Introduction Public health concerns related to high-dose, long-term opioid use for the treatment of persistent pain have reached a fever pitch. These concerns are fueled by the lack of evidence for the effectiveness of opioids in adequately treating or alleviating many chronic pain conditions,1 risks of harmful side effects,2 drug diversion and illicit opioid use,3 addictions,4 and fatal overdoses.5 A significant proportion of chronic pain and problematic opioid use issues can be linked to the acute phase after major surgery, when patients are commonly prescribed opioid analgesics to manage their postsurgical pain.6,7 Most patients are provided little more than pharmacotherapy for pain after surgery and are generally offered no intervention targeting the psychological vulnerability factors that are associated with a greater probability of pain chronicity, including pain catastrophizing,8 sensitivity to pain traumatization,9 anxiety and depressive symptoms.10 In addition, although behavioral interventions have been shown to reduce the impact of persistent pain in terms of reducing pain interference (i.e., the impact of pain on work, sleep, relationships, enjoyment of life, etc.),11 postsurgical patients have not historically been offered these interventions. Furthermore, they are typically offered very little medical or behavioral guidance to support opioid weaning,12 given the general expectation that postsurgical pain will resolve and pain medication use will naturally taper in parallel. However, between 5% and 70% of surgery patients develop chronic postsurgical pain (CPSP), depending in part upon the surgical procedure.13 Moreover, 3% and 0.4% of previously opioid-naïve patients continue to use opioids 3 months7 and 1 year after major surgery, respectively, likely due to persistent postsurgical pain.6 Recent U.S. national guidelines for managing postsurgical pain have emphasized that opioids should not constitute a stand-alone treatment for postoperative pain and should be combined with nonpharmacological approaches to prevent long-term opioid use.12 Patients taking a selective serotonin reuptake inhibitor (SSRI) or a benzodiazepine prior to surgery to treat depression or anxiety have been identified as having the highest risk of persisting on opioids following major surgery.6,14 The combination of postsurgical pain, disability, and continued psychological symptoms can be overwhelming for patients in the early recovery period. Thus, a concerted effort must be made to address depression and anxiety in the months after surgery because they have the potential to amplify pain, pain interference, and opioid use.
What the sources say
- Could not verifycites [6] Clarke H, 2014, BMJ sourceExperimental — accuracy not yet measured
The paper’s “Fiona Godlee editor, BMJ” section discusses minimum alcohol pricing, not opioid use after surgery. Searches for the 0.4% one-year figure and for persistent postsurgical pain found no relevant passage in our copy. (LLM, conf=0.78)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“ACT has garnered significant research support as an effective behavioral chronic pain intervention in a relatively short amount of time17,18 and has been rated as having strong research support in the treatment of chronic pain by Division 12 of the American Psychological Association.19”
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Introduction Public health concerns related to high-dose, long-term opioid use for the treatment of persistent pain have reached a fever pitch. These concerns are fueled by the lack of evidence for the effectiveness of opioids in adequately treating or alleviating many chronic pain conditions,1 risks of harmful side effects,2 drug diversion and illicit opioid use,3 addictions,4 and fatal overdoses.5 A significant proportion of chronic pain and problematic opioid use issues can be linked to the acute phase after major surgery, when patients are commonly prescribed opioid analgesics to manage their postsurgical pain.6,7 Most patients are provided little more than pharmacotherapy for pain after surgery and are generally offered no intervention targeting the psychological vulnerability factors that are associated with a greater probability of pain chronicity, including pain catastrophizing,8 sensitivity to pain traumatization,9 anxiety and depressive symptoms.10 In addition, although behavioral interventions have been shown to reduce the impact of persistent pain in terms of reducing pain interference (i.e., the impact of pain on work, sleep, relationships, enjoyment of life, etc.),11 postsurgical patients have not historically been offered these interventions. Furthermore, they are typically offered very little medical or behavioral guidance to support opioid weaning,12 given the general expectation that postsurgical pain will resolve and pain medication use will naturally taper in parallel. However, between 5% and 70% of surgery patients develop chronic postsurgical pain (CPSP), depending in part upon the surgical procedure.13 Moreover, 3% and 0.4% of previously opioid-naïve patients continue to use opioids 3 months7 and 1 year after major surgery, respectively, likely due to persistent postsurgical pain.6 Recent U.S. national guidelines for managing postsurgical pain have emphasized that opioids should not constitute a stand-alone treatment for postoperative pain and should be combined with nonpharmacological approaches to prevent long-term opioid use.12 Patients taking a selective serotonin reuptake inhibitor (SSRI) or a benzodiazepine prior to surgery to treat depression or anxiety have been identified as having the highest risk of persisting on opioids following major surgery.6,14 The combination of postsurgical pain, disability, and continued psychological symptoms can be overwhelming for patients in the early recovery period. Thus, a concerted effort must be made to address depression and anxiety in the months after surgery because they have the potential to amplify pain, pain interference, and opioid use.
What the sources say
- Supportedcites [17] source
The Introduction says studies supporting ACT’s efficacy and effectiveness for chronic pain developed quickly over six or seven years and lists multiple randomized trials. It cautions that the controlled trials were generally small and preliminary. The separate Division 12 rating in the citing sentence is not attributed to this source. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [18] source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Patients taking a selective serotonin reuptake inhibitor (SSRI) or a benzodiazepine prior to surgery to treat depression or anxiety have been identified as having the highest risk of persisting on opioids following major surgery.6,14”
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Introduction Public health concerns related to high-dose, long-term opioid use for the treatment of persistent pain have reached a fever pitch. These concerns are fueled by the lack of evidence for the effectiveness of opioids in adequately treating or alleviating many chronic pain conditions,1 risks of harmful side effects,2 drug diversion and illicit opioid use,3 addictions,4 and fatal overdoses.5 A significant proportion of chronic pain and problematic opioid use issues can be linked to the acute phase after major surgery, when patients are commonly prescribed opioid analgesics to manage their postsurgical pain.6,7 Most patients are provided little more than pharmacotherapy for pain after surgery and are generally offered no intervention targeting the psychological vulnerability factors that are associated with a greater probability of pain chronicity, including pain catastrophizing,8 sensitivity to pain traumatization,9 anxiety and depressive symptoms.10 In addition, although behavioral interventions have been shown to reduce the impact of persistent pain in terms of reducing pain interference (i.e., the impact of pain on work, sleep, relationships, enjoyment of life, etc.),11 postsurgical patients have not historically been offered these interventions. Furthermore, they are typically offered very little medical or behavioral guidance to support opioid weaning,12 given the general expectation that postsurgical pain will resolve and pain medication use will naturally taper in parallel. However, between 5% and 70% of surgery patients develop chronic postsurgical pain (CPSP), depending in part upon the surgical procedure.13 Moreover, 3% and 0.4% of previously opioid-naïve patients continue to use opioids 3 months7 and 1 year after major surgery, respectively, likely due to persistent postsurgical pain.6 Recent U.S. national guidelines for managing postsurgical pain have emphasized that opioids should not constitute a stand-alone treatment for postoperative pain and should be combined with nonpharmacological approaches to prevent long-term opioid use.12 Patients taking a selective serotonin reuptake inhibitor (SSRI) or a benzodiazepine prior to surgery to treat depression or anxiety have been identified as having the highest risk of persisting on opioids following major surgery.6,14 The combination of postsurgical pain, disability, and continued psychological symptoms can be overwhelming for patients in the early recovery period. Thus, a concerted effort must be made to address depression and anxiety in the months after surgery because they have the potential to amplify pain, pain interference, and opioid use.
What the sources say
- Could not verifycites [6] Clarke H, 2014, BMJ sourceExperimental — accuracy not yet measured
The ‘Fiona Godlee editor, BMJ’ section discusses minimum alcohol pricing and industry lobbying, not postoperative opioid use. Searches for SSRIs, benzodiazepines, and preoperative medication as predictors of persistent opioid use found no relevant passage in our copy. (LLM, conf=0.78)
- Partly supportedcites [14] sourceExperimental — accuracy not yet measured
The Results report that preoperative benzodiazepine use (OR 1.82) and antidepressant use (OR 1.65) were associated with chronic opioid use after surgery. The Methods classify antidepressants as a group, not SSRIs specifically, and do not establish that the prescriptions were for depression or anxiety. The Results also show a higher odds ratio for a history of drug abuse (OR 3.15), so these medication users were not identified as having the highest risk. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There is a dearth of research investigating the efficacy of psychosocial treatments in reducing opioid use among people living with chronic pain.42,43”
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Discussion
What the sources say
- Partly supportedcites [42] Garland EL, 2014, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The passage under Abstract > Conclusions says there is scant research on psychological treatments that simultaneously address chronic pain and prescription opioid misuse. The claim broadens this to reducing opioid use generally, rather than misuse. The Discussion also says this trial did not quantify changes in opioid dosing. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [43] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
45 more claims · 2 with their cited sources checked
Create a free account to see all 94 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, traditional ACT interventions require a clinic-based, interdisciplinary team approach, which is not always feasible for both patients and health care systems [17,18].”
From Acceptance and Commitment Therapy Delivered via a Mobile Phone Messaging Robot to Decrease Postoperative Opioid Use in Patients With Orthopedic Trauma: Randomized Controlled Trial (Preprint) (2020) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Improved mood symptoms, less pain interference, and faster cessation of opioid pain medication are some of the recognized benefits of using ACT in clinic-based, interdisciplinary approaches to pain management after surgery [17,18].”
From Acceptance and Commitment Therapy Delivered via a Mobile Phone Messaging Robot to Decrease Postoperative Opioid Use in Patients With Orthopedic Trauma: Randomized Controlled Trial (Preprint) (2020) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a randomized trial on at-risk veterans undergoing orthopedic surgery and in a non-randomized trial on patients receiving mixed surgical procedures, the groups receiving ACT-based treatments showed reduced recovery time and less prolonged opioid consumption than control groups.10,11”
From Acceptance and commitment therapy for prevention of chronic pain after total knee arthroplasty. (2026) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, the use of ACT as a preventive intervention for chronic post-surgical pain and prolonged opioid use is still novel.”
From Acceptance and Commitment Therapy for Prevention of Chronic Postsurgical Pain and Opioid Use in At-Risk Veterans: A Pilot Randomized Controlled Study. (2018) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“To date, there has only been one non-randomized study1 and a detailed case report42 describing the effects of ACT on CPSP and opioid use.”
From Acceptance and Commitment Therapy for Prevention of Chronic Postsurgical Pain and Opioid Use in At-Risk Veterans: A Pilot Randomized Controlled Study. (2018) · cites this paper as [1]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“F(1, 274) = 12.74, P > 0.001”
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Results > Opioid use
Reported p > .001 · recomputed p < .001
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upF(1, 274) = 12.74reported p > .001 · recomputed p < .001
“F(1, 274) = 12.74, p > .001”
- ConsistentF(1, 326) = 8.08reported p = .005 · recomputed p = .005
“F(1, 326) = 8.08, p = .005”
- Consistentχ²(1) = 17.38reported p < .001 · recomputed p < .001
“χ2(1) = 17.38, p < .001”
- Consistentχ²(1) = 40.69reported p < .001 · recomputed p < .001
“χ2(1) = 40.69, p < .001”
- Consistentχ²(1) = 51.02reported p < .001 · recomputed p < .001
“χ2(1) = 51.02, p < .001”
19 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Results > Opioid use
“The simple main effect of group was significant at the first TPS visit, F(2, 274) = 18.18, P < 0.001, = 0.06, indicating that the ACT group had significantly higher MED than the no ACT group at baseline (P < 0.001).”
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Abstract
“Pain, pain interference, sensitivity to pain traumatization, pain catastrophizing, anxiety, depression, and opioid use were analyzed using two-way (Group [ACT, no ACT] × Time [first, last visit]) analyses of variance (ANOVAs).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Results > Sensitivity to pain traumatization
“ANOVA revealed a significant main effect of group, F(2, 136) = 4.63, P < 0.05, = 0.03, indicating that the ACT group had significantly higher sensitivity to pain traumatization scores than the no ACT group at both time points (Table 3).”
§ Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service > Abstract
“Pain, pain interference, sensitivity to pain traumatization, pain catastrophizing, anxiety, depression, and opioid use were analyzed using two-way (Group [ACT, no ACT] × Time [first, last visit]) analyses of variance (ANOVAs).”
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · cited 1×
“clinical cutoffs for the HADS are 8–10 for mild, 11–15 for moderate, and ≥16 for severe depression or anxiety.(37) The HADS has demonstrated good internal consistency in clinical samples (HADS-A; α = 0.”
BackgroundThe Pain Catastrophizing Scale: Development and validation.
Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995) · Psychological Assessment · doi:10.1037//1040-3590.7.4.524 · Cited by 8,227
Pain assessment: global use of the Brief Pain Inventory.
Cs, C., & Km, R. (1994) · PubMed · Cited by 5,421
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471 · cited 2×
“Nonetheless, the mean reductions in pain intensity of the ACT group fell within the 10%–20% range considered to reflect minimally important changes on the 0–10 pain NRS.46 Taken together with the ACT group’s reductions in pain interference, this finding is consistent with the literature on ACT interventions that have…”
ResultEta squared and partial eta squared as measures of effect size in educational research
Richardson, J. T. E. (2011) · Educational Research Review · doi:10.1016/j.edurev.2010.12.001 · Cited by 3,465 · cited 1×
“14).(40) Wilk’s Lambda values (^) were used to interpret the percent variance in dependent”
MethodChou, R., Gordon, D. B., de Leon-Casasola, O. A., Rosenberg, J. M., Bickler, S., Brennan, T., Carter, T., Cassidy, C. L., Chittenden, E. H., Degenhardt, E., et al. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2015.12.008 · Cited by 3,171 · cited 2×
“concerns continue to rise with regard to the risks of long-term, high-dose opioid use(44) and dose escalation triggered by postsurgical opioid prescribing practices with little in the way of opioid tapering assistance.(12) The present study provides preliminary evidence that there is a potentially powerful role for be…”
BackgroundOpioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
The clinical use of mindfulness meditation for the self-regulation of chronic pain
Kabat-Zinn, J., Lipworth, L., & Burney, R. (1985) · Journal of Behavioral Medicine · doi:10.1007/bf00845519 · Cited by 1,745
Research works printed but not linked: 10
- Katz J, 2015, J Pain Res, 8, 695–702
- Polk KL, 2016, The essential guide to the ACT matrix: a step-by-step approach to using the ACT matrix model in clinical practice
- Hayes SC, Acceptance and commitment therapy: The process and practice of mindful change
- Young S., 2011, Boulder, CO: Sounds True
- Kapstad H, 2010, Health Qual Life Outcomes, 148, 1–8
- Katz J, 2017, J Pain Res.
- Fashler SR, Research Poster Abstracts of the 2017 Canadian Pain Society Annual Meeting. Can J Pain. 2017;1(1);A93–A94
- Fashler S, 2016, Paper presented at: 37th Annual Canadian Pain Society Scientific Meeting Annual Meeting
- MD Anderson Cancer Center. Cancer Pain-Adult Medical Algorithm, MD Anderson Cancer Center; 2015 June [accessed 2017 January]
- Darnall BD, 2014, J Pain Res, 7, 1–8
Cited by
Inappropriate opioid prescription after surgery
Neuman, M. D., Bateman, B. T., & Wunsch, H. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30428-3 · Cited by 408
Weinrib, A. Z., Azam, M. A., Birnie, K. A., Burns, L. C., Clarke, H., & Katz, J. (2017) · British Journal of Pain · doi:10.1177/2049463717720636 · Cited by 178
Self-citationDindo, L., Zimmerman, M. B., Hadlandsmyth, K., StMarie, B., Embree, J., Marchman, J., Tripp-Reimer, T., & Rakel, B. (2018) · The Journal of Pain · doi:10.1016/j.jpain.2018.04.016 · Cited by 121
Katz, J., Weinrib, A. Z., & Clarke, H. (2019) · Canadian Journal of Pain · doi:10.1080/24740527.2019.1574537 · Cited by 87
“ing psychological services (no ACT group) on measures of pain, pain interference, key psychological constructs, and opioid use for the duration of TPS treatment.(64)”
Self-citationClarke, H., Azargive, S., Montbriand, J., Nicholls, J., Sutherland, A., Valeeva, L., Boulis, S., McMillan, K., Ladak, S. S. J., Ladha, K., et al. (2018) · Canadian Journal of Pain · doi:10.1080/24740527.2018.1501669 · Cited by 84
“interventions for pain and addiction as part of their multimodal approach.(16) Physiotherapists and other allied health professionals offer other services based on patient need.”
BackgroundSelf-citation
Metadata
- Authors
- Abid Azam, M., Weinrib, A. Z., Montbriand, J., Burns, L. C., McMillan, K., Clarke, H., & Katz, J.
- Affiliations
- Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, Toronto, Ontario, Canada
- York University (CA)
- Toronto General Hospital (CA)
- Corresponding author
- Weinrib, Aliza Z.
- Venue
- Canadian Journal of Pain
- Publisher
- Informa UK Limited
- Published
- 2017-01-01
- Volume
- 1
- Issue
- 1
- Pages
- 37-49
- ISSN
- 2474-0527 (ISSN-L)
- PMC
- PMC8730651
- OpenAlex
- W2729181381
- Cited by
- 90
- References
- 52
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 12 · 2023: 13 · 2022: 9 · 2021: 8 · 2020: 9 · 2019: 12 · 2018: 9 · 2017: 3
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Canadian Journal of Pain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Ontario Ministry of Health and Long-Term Care
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- acceptance and commitment therapy, chronic postoperative pain, opioid use, opioid tapering, transitional pain service, pain catastrophizing, pain interference, anxiety, depression, pain sensitivity, psychological intervention, major surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service. https://app.cochat.ai/papers/10.1080/24740527.2017.1325317
- The paper
- Abid Azam, M., Weinrib, A. Z., Montbriand, J., Burns, L. C., McMillan, K., Clarke, H., & Katz, J. (2017). Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service. Canadian Journal of Pain. https://doi.org/10.1080/24740527.2017.1325317
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.